Press Kit

Texts

One-liner:

Fanny Giannou is a biotech entrepreneur and CEO of Alithea Bio — one of Europe’s most recognised deep-tech founders in precision cancer immunotherapy.

Biography:

Fanny is a visionary leader and entrepreneur, renowned for her transformative impact in the
energy and biotech sector and her drive to turn bold ideas into reality. With over 15 years of
experience in senior leadership positions in corporates, she has on parallel successfully
founded and led several ventures, consistently demonstrating her expertise in market
making, team building, and strategic growth.
As the CEO and Founder of Alithea Bio, a biotech company with the mission of unfolding the
power of immunotherapies to cure cancer diseases, Fanny holds an Executive MBA from ETH
Zürich and the University of St. Gallen, credentials that underscore her commitment to
excellence and innovation. Fanny has been awarded with the Women TechEU Award 2024
and with the CyberChampions Award 2024.
Her leadership is fueled by her vision: a world where cancer is not a deadly disease but a
curable one. This vision drives her mission to build and nurture diverse teams, inspiring them
daily to push the boundaries of what’s possible in the pursuit of life-saving solutions.
Beyond her professional achievements, Fanny is a passionate mentor, dedicated to
empowering young entrepreneurs and inspiring young girls to pursue their dreams. She
believes in the power of cutting-edge technologies to create meaningful change and is
committed to a future where innovation leads to a better, healthier world for all.